87 related articles for article (PubMed ID: 1713039)
1. [Oromaxillofacial cancer. Development of therapeutic approach and results].
Vallecillo Capilla M; Valencia Laseca E
Rev Actual Odontoestomatol Esp; 1991 Apr; 51(402):49-52, 55-6, 59-60. PubMed ID: 1713039
[TBL] [Abstract][Full Text] [Related]
2. [A preliminary report of the Chinese Corynebacterium vaccine with pingyangmycin on the treatment of squamous cell carcinoma of the oral and maxillofacial region].
Zhou ZY
Zhonghua Kou Qiang Ke Za Zhi; 1984 Dec; 19(4):199-202. PubMed ID: 6085726
[No Abstract] [Full Text] [Related]
3. [The therapy of carcinomas in the oromaxillofacial area. IV. Carcinomas of the buccal mucosa].
Tartaro S; Giudice M; Colella G; Stroffolini FA
Minerva Stomatol; 1990 Jan; 39(1):53-6. PubMed ID: 2329976
[TBL] [Abstract][Full Text] [Related]
4. [Clinical studies of B-M therapy in oral cancer with multidisciplinary treatment].
Fukazawa H; Sekiyama S; Yuki K; Matsumoto D; Takase K; Segawa A; Takamaru H
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):112-8. PubMed ID: 2422306
[No Abstract] [Full Text] [Related]
5. [Effect of combined treatment with radiation therapy and peplomycin on carcinoma of the oral cavity].
Shimizutani K; Masaki N; Ikeda H; Nishiyama K; Inoue T; Fuchihata H
Rinsho Hoshasen; 1988 Sep; 33(9):967-71. PubMed ID: 2461458
[No Abstract] [Full Text] [Related]
6. [The efficacy and side effects of the preoperative administration of pingyangmycin in squamous cell carcinoma of the oro-maxillo-facial region].
Zhao FY
Zhonghua Kou Qiang Ke Za Zhi; 1985 May; 20(3):150-3, 190-1. PubMed ID: 2417789
[No Abstract] [Full Text] [Related]
7. [Individualized tumor therapy based on biological parameters and prognostic evaluation using the TPI (therapy-oriented prognostic index)].
Hyckel P; Mansel B; Schumann D; Ahlendorf W; Müller P; Hoyer H
Fortschr Kiefer Gesichtschir; 1992; 37():56-8. PubMed ID: 1639315
[No Abstract] [Full Text] [Related]
8. Oral malignancies in a community hospital tumor clinic.
Pizer ME
Va Med Mon (1918); 1970 Mar; 97(3):167-70. PubMed ID: 5528094
[No Abstract] [Full Text] [Related]
9. [Comparative investigation of effect of preoperative treatment and "safe margin" in oral squamous cell carcinoma].
Ohno A; Osaki T; Kato I; Yoneda K; Hirota S; Ogawa Y
Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2234-42. PubMed ID: 2434587
[No Abstract] [Full Text] [Related]
10. [Primary cytostatic therapy of progressive squamous cell carcinoma of the oral cavity].
Bienengräber V
Arch Geschwulstforsch; 1986; 56(5):353-6. PubMed ID: 2429630
[TBL] [Abstract][Full Text] [Related]
11. [The potentials for optimizing the treatment of III-stage squamous cell cancer of the oral mucosa].
Liubaev VL; Paches AI; Brzhezovskiĭ VZh; Chuprik-Malinovskaia TP
Vopr Onkol; 1990; 36(10):1251-5. PubMed ID: 2251825
[No Abstract] [Full Text] [Related]
12. [Combination surgery - bleomycin therapy in squamous-cell carcinoma of the oral cavity].
Lübbe H; Schüle H; Kehrer F; Kraus B
Fortschr Kiefer Gesichtschir; 1976; 21():218-20. PubMed ID: 61933
[No Abstract] [Full Text] [Related]
13. [The clinical application and evaluation of combined chemotherapy in comprehensive treatment for oral squamous cell carcinoma].
Liu S; Liao C; Wang D
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):109-11. PubMed ID: 12838692
[TBL] [Abstract][Full Text] [Related]
14. An effective combined therapy for advanced squamous cell carcinoma of the oral cavity: preoperative BVMM (bleomycin, vincristine, mitolactol plus methotrexate and leucovorin) chemotherapy followed by surgery.
Olasz L; Szabó I; Horváth A
Neoplasma; 1988; 35(5):591-7. PubMed ID: 3216933
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of buccal epidermoid carcinoma. Up-to-date review].
Reychler H
Ann Chir Plast Esthet; 1991; 36(6):486-97. PubMed ID: 1726348
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of squamous carcinoma of the floor of the mouth--an analysis of 33 cases].
Miao YJ
Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):37-8. PubMed ID: 3979248
[No Abstract] [Full Text] [Related]
17. [Studies on treatment and results of cancer of the buccal cavity].
Ueno T
Kokubyo Gakkai Zasshi; 1969 Mar; 36(1):4-19. PubMed ID: 5257442
[No Abstract] [Full Text] [Related]
18. [Treatment of advanced neoplasms in the jaw].
Dimopoulos J; Hollmann K; Kühböck J
Strahlentherapie; 1975 Apr; 149(4):346-52. PubMed ID: 49096
[TBL] [Abstract][Full Text] [Related]
19. Immunological differences between squamous cell cancer patients treated with and without biological response modifier (OK-432): evaluation at a period of more than one year after the last treatment.
Yoshimura Y; Oka M; Harada T; Inou Y; Saito H; Odagawa T; Matsumoto K
J Osaka Univ Dent Sch; 1989 Dec; 29():117-22. PubMed ID: 2577382
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies of two patient groups with primary mouth cancer 1981 to 1989].
Krifka FJ; Drommer RB; Kristen K; Hothorn L; Zöller J
Fortschr Kiefer Gesichtschir; 1992; 37():40-3. PubMed ID: 1639308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
